Search

Filters

Clear Filters
5:20 PM - 5:30 PM ET

145 - Federated Deep Ensemble Learning for MRI-Based Brain Metastasis Segmentation: An International Multi-Center Development
Speaker: Zhao, Jingtong, MS, BS - Duke University, Durham, NC
5:30 PM - 5:40 PM ET

146 - Cross-Institutional Validation of a Mixed-Cohort-Trained 3D Res-U-Net for Cervical-Bed CTV Segmentation in Cervical Cancer Radiotherapy
Speaker: You, Weir Chiang, MD, PhD - Taichung Veterans General Hospital, Taichung, Taichung
5:40 PM - 5:50 PM ET

147 - An Integrated AI Framework for Automated Cardiac Substructure Segmentation and Cardiotoxicity Risk Mitigation in Lung Cancer
Speaker: Chen, Xinru, PhD - Baylor College of Medicine, Houston, TX
5:50 PM - 6:00 PM ET

148 - Branching Out: A Deep Learning Framework for Precise Coronary Artery Delineation in Radiation Therapy
Speaker: Ruff, Chase, MS - University of Wisconsin-Madison, Madison, WI
8:00 AM - 8:10 AM ET

149 - Impact of Patient Navigation in a Cancer Center-Community Partnership on Short-Course Radiation Therapy Access for African-American Breast Cancer Patients: Early Results of the Navigator-Assisted Hypofractionation (NAVAH) Program
Speaker: Ofori-Darko, Afua, BS - Case Western Reserve School of Medicine, Cleveland, OH
8:10 AM - 8:20 AM ET

150 - Development and Implementation of the SOaR² Spine Oncology Program: Expanding Access to Complex Multidisciplinary Care
Speaker: Adelizzi, Alyssa, MSN - Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
8:20 AM - 8:30 AM ET

151 - Improving Access to Conformal Bolus Using Sheet Bolus and Piece-Wise Flat Geometry
Speaker: Stambaugh, Cassandra, PhD - Tufts Medical Center, Boston, MA
8:30 AM - 8:40 AM ET

152 - National Expansion and Radiation Oncology Participation in Radiopharmaceutical Therapy: Medicare Provider Trends 2013-2023
Speaker: Maroongroge, Sean, MD, MBA - City of Hope National Medical Center, Duarte, CA
8:40 AM - 8:50 AM ET

153 - Alternative Cancer Treatment Clinics in the United North America: Evidence Gaps, Regulatory Concerns, and Financial Burden
Speaker: El Kouzi, Zakaria, MD - MD Anderson Cancer Center, Houston, TX
8:00 AM - 8:10 AM ET

154 - Is Clinical Target Volume Necessary in Limited-Stage Small Cell Lung Cancer? A Large-Scale Comparative Study
Speaker: Wang, Xiaolong - Cancer Center, Shandong University, Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong, Jin, jinan
8:10 AM - 8:20 AM ET

155 - Post-Chemoradiotherapy Molecular Residual Disease (MRD) Clearance Determines Long-Term Survival in Limited-Stage Small Cell Lung Cancer: A Prospective Longitudinal Study
Speaker: Tian, Yaru - Shandong Cancer Hospital and Institute, Jinan
8:20 AM - 8:30 AM ET

156 - Prognostic Value of Baseline Genomic Profiling and Longitudinal ctDNA-Based MRD Monitoring in Limited-Stage Small-Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
Speaker: Huo, Siyuan - Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer and Tianjin Key Laboratory of Cancer Prevention and Therapy, Ti, Tianjin